Adrenergic Bronchodilators and Potassium Mika Scheinin, M.D., Markku Koulu, M.D., Esa Laurikainen, M.D. CHEST Volume 91, Issue 5, Pages 794-795 (May 1987) DOI: 10.1016/S0012-3692(16)58834-5 Copyright © 1987 The American College of Chest Physicians Terms and Conditions
FIGURE 1.1 Average (± SD) maximal reductions in plasma potassium after placebo (P), albuterol (S) and fenoterol (F), administered by inhalation. The doses were 1,080 (2), 1,400 (3) and 2,160 µg (4) in one hour. CHEST 1987 91, 794-795DOI: (10.1016/S0012-3692(16)58834-5) Copyright © 1987 The American College of Chest Physicians Terms and Conditions